REFERENCES:
1. Chest 1996; Arita T, Matsumoto T, Kuramitsu T, et al. Is it possible to differentiate malignant mediastinal nodes from benign nodes by size? Reevaluation by CT, transesophageal echocardiography, and nodal specimen. 110: 1004-08
2. J Clin Onc 1998; Eberhardt W, Wilke H, Stamatis G, et al. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small cell lung cancer: Mature results of a phase II trial. 16: 622-34
3. Chest 1997; Mountain CF. Revisions in the international system for staging lung cancer. 111: 1710-17
4. J Nucl Med 1996; Gambhir SS, Hoh CK, Phelps ME, et al. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. 37: 1428-1436
5. Chest 1997; Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging. 111: 1718-23
6. Chest 1991; Bains MS. Surgical treatment of lung cancer. 100: 826-37
7. Ann Thorac Surgery 1988; Naruke T, Goya T, Tsuchiya R, et al. The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastases. 46: 603-10
8. Radiology 1989; Glazer HS, Kaiser LR, Anderson DJ, et al. Indeterminate mediastinal invasion in bronchogenic carcinoma: CT evaluation. 173: 37-42
9. N Engl J Med 1994; Rosell R, Gomez-Codina J, Camps C, et al. A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer. 330: 153-58
10. J Thorac Cardiovasc Surg 1994; Warren WH, Faber P. Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma. 107: 1087-94
11. South Med J 1992; Beale R, Slater R, Hennington M, et al. Pancoast tumor: Use of MRI for tumor staging. 85: 1260-63
12. Ann Thorac Surg 1997; Detterbeck FC. Pancoast (superior sulcus) tumors. 63; 1810-18
13. N Engl J Med 1997; Arcasoy SM, Jett JR. Superior sulcus tumors and Pancoast's syndrome. 337: 1370-76
14. Radiology 1989; Heelan RT, Demas BE, Caravelli JF, et al. Superior sulcus tumors: CT and MR imaging. 170: 637-641
15. Ann Thorac Surg 1997; Nakanishi R, Osaki T, Nakanishi K, et al. Treatment strategy for patients with surgically discovered N2 stage IIIA non-small cell lung cancer. 64: 342-48
16. Ann Thorac Surg 1997; Sawyer TE, Bonner JA, Gould PM, et al. Effectiveness of postoperative irradiation in stage IIIA non-small cell lung cancer according to regression tree analyses of recurrence risks. 64: 1402-08
17. Chest 1997; Vansteenkiste JF, Stroobants SG, DeLeyn PR, et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer. A prospective analysis of 50 cases. 112: 1480-86
18. Ann Thorac Surg 1997; Vansteenkiste JF, DeLeyn PR, Deneffe GJ, et al. Survival and prognostic factors in resected N2 non-small cell lung cancer: A study of 140 cases. 63: 1441-50
19. AJR 1988; Sider L, Horejs D. Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT. 151: 893-95
20. Heme-Onc Clinics of North Am 1997; Mentzer SJ. Mediastinoscopy, thoracoscopy, and video-assisted thoracic surgery in the diagnosis and staging of lung cancer. 11: 435-47
21. Ann Thorac Surg 1996; Yoshino I, Yokoyama H, Yano T, et al. Skip metastases to the mediastinal lymph nodes in non-small cell lung cancer. 62: 1021-25
22. Radiol Clin North Am 1990; Chiles C. CT of the pulmonary hilum. 28: 539-53
23. Heme-Onc Clinics of North Am 1997; Shaffer K. Imaging and medical staging of lung cancer. 11: 197-213
24. AJR 1988; Kiyono K, Sone S, Sakai F, et al. The number and size of normal mediastinal lymph nodes: A postmortem study. 150: 771-76
25. AJR 1984; Genereux GP, Howie JL. Normal mediasitnal lymph node size and number: CT and anatomic study. 142: 1095-1100
26. Semin Roentgen 1990; Libshitz HI. Computed tomography in bronchogenic carcinoma. 25: 64-72
27. AJR 1884; Libshitz HI, McKenna RJ. Mediastinal lymph node size in lung cancer. 143: 715-18
28. Chest 1995; Pugatch RD. Radiologic evaluation in chest malignancies. A review of imaging modalities. 107: 294S-97S
29. Chest 1994; Grover FL. The role of CT and MRI in staging of the mediastinum. 106: 391S-96S
30. Radiology 1992; McCloud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: Analysis of staging in mediastinum with CT by correlative lymph node mapping and sampling. 182: 319-23
31. Ann Thorac Surg 1990; Lewis JW, Pearlberg JL, Beute GH, et al. Can computed tomography of the chest stage lung cancer?- Yes and no. 49: 591-96
32. Chest 1985; McKenna RJ, Libshitz HI, Mountain CF, et al. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer. 88: 206-10
33. Radiology 1988; Gross BH, Glazer GM, Orringer MB, et al. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: Freqency and signficance. 166: 71-74
34. Radiology 1988; Scott IR, Muller NL, Miller RR, et al. Resectable stage III lung cancer: CT, surgical, and pathologic correlation. 166: 75-79
35. Radiology 1988; Staples CA, Muller NL, Miller RR, et al. Mediastinal nodes in bronchogenic carcinoma: Comparison between CT and mediastinoscopy. 167: 367-372
36. Radiology 1997; Shimoyama K, Murata K, Takahashi M, et al. Pulmonary hilar lymph node meyastases from lung cancer: Evaluation based on morphology at thin-section, incremental, dynamic CT. 203: 187-95
37. AJR 1985; Glazer GM, Gross BH, Aisen AM, et al. Imaging of the pulmonary hilum: A prospective comparative study in patients with lung cancer. 145: 245-48
38. AJR 1996; Murata K, Takahashi M, Mori M, et al. Peribronchovascular interstitium of the pulmonary hilum: Normal and abnormal findings on thin-section electron-beam CT. 166: 309-12
39. Radiology 1995; Remy-Jardin M, Duyck P, Remy J, et al. Hilar lymph nodes: Identification with spiral CT and histologic correlation. 196: 387-394
40. Radiology 1994; Primack SL, Lee KS, Logan PM, et al. Bronchogenic carcinoma: Utility of CT in the evaluation of patients with supected lesions. 193: 795-800
41. J Comput Assist Tomogr 1993; Webb WR, Sarin M, Zerhouni EA, et al. Interobserver variability in CT and MR staging of lung cancer. 17: 841-46
42. Radiology 1989; Conces DJ, Klink JF, Tarver RD, et al. T1N0M0 lung cancer: Evaluation with CT. 170: 643-46
43. Radiology 1993; Seeley JM, Mayo JR, Miller RR, et al. T1 lung cancer: Prevalence of mediastinal node metastases and diagnostic accuracy of CT. 186: 129-132
44. AJR 1986; Heavey LR, Glazer GM, Gross BH, et al. The role of CT in staging radiographic T1N0M0 lung cancer. 146: 285-90
45. J Thorac Imaging 1991; Onitsuka H, Tsukuda M, Araki A, et al. Differentiation of central lung tumor from postobstructive lobar collapse by rapid sequence computed tomography. 6: 28-31
46. AJR 1985; Pennes DR, Glazer GM, Wimbish KJ, et al. Chest wall invasion by lung cancer: Limitations of CT evaluation. 144: 507-11
47. Radiology 1993; Padovani B, Mouroux J, Seksik L, et al. Chest wall invasion by bronchogenic carcinoma: Evaluation with MR imaging. 187: 33-38
48. Ann Thorac Surg 1991; Ratto GB, Piacenza G, Frola C, et al. Chest wall involvement by lung cancer: Computed tomographic detection and results of operation. 51: 182-88
49. AJR 1987; Hagger AM, Pearlberg JL, Froelich JW, et al. Chest wall invasion by carcinoma of the lung: Detection by MR imaging. 148: 1075-78
50. Radiology 1985; 157: Glazer HS, Duncan-Meyer J, Aronberg D, et al. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation. 157: 191-94
51. AJR 1991; Watanabe A, Shimokata K, Saka H, et al. Chest CT with artificial pneumonthorax: Value in determining origin and extent of tumor. 156: 707-10
52. Radiology 1991; Yokoi K, Mori K, Miyazawa N, et al. Tumor invasion of the chest wall and mediastinum in lung cancer: Evaluation with pneumothorax CT. 181: 147-152
53. Radiology 1994; Kuriyama K, Tateishi R, Kumatani T, et al. Pleural invasion by peripheral bronchogenic carcinoma: Assessment with three-dimensional helical CT. 191: 365-369
54. Radiol Clin North Am 1995; Touliopoulos P, Costello P. Helical (spiral) CT of the thorax. 33: 843-861
55. Radiology 1994; Herman SJ, Winton Tl, Weisbrod GL, et al. Mediastinal invasion by bronchogenic carcinoma: CT signs. 190: 841-46
56. Radiology 1993; Suzuki N, Saitoh T, Kitamura S. Tumor invasion of the chest wall in lung cancer: Diagnosis with US. 187: 39-42
57. Chest 1990; Salvatierra A, Baamonde C, Llamas JM, et al. Extrathoracic staging of bronchogenic carcinoma. 97: 1052-58
58. Ann Thorac Surg 1994; Hatter J, Kohman LJ, Mosca RS, et al. Preoperative evaluation of stage I and stage II non-small cell lung cancer. 58: 1738-41
59. Radiology 1984; Oliver TW, Bernardino ME, Miller JI, et al. Isolated adrenal masses in nonsmall-cell bronchogenic carcinoma. 153: 217-18
60. Acad Radiol 1997; Chen MY, Chiles C, Choplin RH, et al. Bronchogenic carcinoma: A survey of CT protocols for staging disease. 4: 687-92
61. Cancer 1990; Salbeck R, Grau H, Artmann H. Cerebral tumor staging in patients with bronchial carcinoma by computed tomography. 66: 2007-11
62. Radiology 1984; Tarver RD, Richmond BD, Klatte EC. Cerebral metastases from lung carcinoma: Neurological and CT correlation. 153: 689-92
63. AJR 1992; Jones EC, Chezmar JL, Nelson RC. The frequency and significance of small (less than or equal to 15 mm) hepatic lesions detected by CT. 158: 535-39
64. Radiol Clin North Am 1994; Jul 32(4):795-809
65. Radiology 1991; Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the radiologic diagnostic oncology group. 178: 705-13
66. J Thorac Imaging 1993; Kono M, Adachi S, Kusumoto M, et al. Clinical utility of Gd-DTPA-enhanced magnetic resonance imaging in lung cancer. 8: 18-26
67. J Comput Assist Tomogr 1989; McLoud TC, Filion RB, Edelman, et al. MR imaging of superior sulcus carcinoma. 13: 233-39
68. J Thorac Imaging 1991; Bourgouin PM, McCloud TC, Fitzgibbon JF, et al. Differentiation of bronchogenic carcinoma from postobstructive pneumonitis by magnetic resonance imaging: Histopathologic correlation. 6: 22-27
69. J Thorac Imaging 1988; Kameda K, Adachi S, Kono M. Detection of the T-factor in lung cancer using magnetic resonance imaging and computed tomography. 3: 73-80
70. Chest 1989; Glazer GM. Radiologic staging of lung cancer using CT and MRI. 96: 44S-47S
71. AJR 1984; Glazer GM, Orringer MB, Gross BH, et al. The mediastinum in non-small cell lung cancer: CT-surgical correlation. 142: 1101-05
72. Radiology 1988; Glaze Gm, Orringer MB, Chenevert TL, et al. Mediastinal lymph nodes: Relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. 168: 429-431
73. Ann Thorac Surg 1997; Yoshino I, Nakanishi R, Osaki T, et al. Preoperative prognosis in patients with non-small cell lung cancer with synchronous ipsilateral intrapulmonary metastases. 64: 809-13
74. Chest 1995; Patz EF, Lowe VJ, Goodman PC, et al. Thoracic nodal staging with PET imaging with 18-FDG in patients with bronchogenic carcinoma. 108: 1617-21
75. Heme-Onc Clinics of North Am 1997; Shaffer K. Imaging and medical staging of lung cancer. 11: 197-213
76. J Nucl Med 1998; Higashi K, Nishikawa T, Seki H, et al. Comparison of flourine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer. 39: 9-15
77. Radiology 1994; Patz EF, Lowe VJ, Hoffman JM, et al. Persistent or recurrent bronchogenic carcinoma: Detection with PET and 2-[F-18]-2-deoxy-D-glucose. 191: 379-382
78. Radiology 1994; Wahl RL, Quint LE, Greenough RL, et al. Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation. 191: 371-377
79. Radiology 1997; Steinert JC, Hauser M, Allemann F, et al. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. 202: 441-446
80. Ann Thorac Surg 1995; Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographi imaging. 60: 1573-82
81. Thorax 1997; Guhlmann A, Storck M, Kotzerke J, et al. Lymph node staging in non-small cell lung cancer: evaluation by [18F] FDG positron emission tomography (PET). 52: 438-441
82. Am J Respir Crit Care Med 1995; Chin R, Ward R, Keyes JW, et al. Mediastinal staging of non-small cell lung cancer with positron emission tomography. 152: 2090-6
83. Lancet 1994; Lewis P, Griffin S, Marsden, et al. Whole-body 18-F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. 344: 1265-1266
84. Semin Nucl Med 1997; Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: Will it replace the other modalities? 27: 94-106
85. J Thorac Imaging 1997; Klein JS, Zarka MA. Transthoracic needle biopsy: an overview. 12: 232-49
86. AJR 1997; Boiselle PM, Shepard JA, Mark EJ, et al. Routine addition of an automated biopsy device to fine-needle aspiration of the lung: a prospective assessment. 169 : 661-66
87. AJR 1996; Li H, Boiselle PM, Shepard JO, et al. Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. 167: 105-109
88. Radiology 1996; Kazerooni EA, Lim FT, Mikhail A, et al. Risk of pneumothorax in CT-guided transthoracic needle aspiration biopsy of the lung. 198: 371-75
89. Radiology 1996; Yankelevitz DF, Davis SD, Henschke CI. Aspiration of a large pneumothorax resulting from transthoracic needle biopsy. 200: 695-97
90. Radiology 1997; Brown KT, Brody LA, Getrajdman GI, et al. Outpatient treatment of iatrogenic pneumothorax after needle biopsy. 205: 249-52
91. J Thorac Imag 1997; Moore EH. Needle-aspiration lung biopsy: A comprehensive approach to complication reduction. 12: 259-271
92. J Thorac Imag 1998; Ayar D, et al. Needle-track metastasis after transthoracic needle biopsy. 13: 2-6
93. AJR 1998; Hayashi N, et al. CT-guided biopsy of pulmonary nodules less than 3 cm: Usefulness of the spring-operated core biopsy needle and frozen-section pathologic diagnosis. 170: 329-331
94. Chest 1997; Detterbeck FC, Socinski MA. IIB or not IIB: the current question in staging non-small cell lung cancer. 112: 229-234
95. J Thorac Imag 1997; Moore EH. Needle-aspiration lung biopsy: A comprehensive approach to complication reduction. 12: 260
96. Chest 1994; Ginsberg RJ, Rubinstein L. The comparison of limited resection to lobectomy for T1N0 non-small cell lung cancer. 106: 318S-319S
97. Curr Probl Cancer 1998; Sweeney CJ, Sandler AB. Treatment of advanced (stages III and IV) non-small cell lung cancer. 22: 83-132
98. J Thorac Cardiovasc Surg 1998; Okada M, et al. Operative approach for multiple primary lung carcinomas. 115: 836-840
99. Eur J Radiol 1996; Bonomo L, et al. Lung cancer staging: the role of computed tomography and magnetic resonance imaging. 23: 35-45
100. AJR 1998; Erasmus JJ, et al. Evaluation of primary pulmonary carcinoid tumors using FDG PET. 170: 1369-1373
101. AJR 1998; Kim BT, et al. Localized form of bronchoalveolar carcinoma: FDG PET findings. 170: 935-939
102. Radiology 1998; Lucidarme O, et al. Intrapulmonary lesions: Percutaneous automated biopsy with a detachable, 18-gauge, coaxial cutting needle. 207: 759-765
103. AJR 1998; Zeman RK, et al. Helical body CT: Evolution of scanning protocols. 170: 1427-1438
104. AJR 1998; Cascade PN, et al. Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: A comparison of contrast-enhanced and unenhanced CT. 170: 927-931
105. J Comput Assist Tomogr 1998; Choe DH, et al. Obliteration of the pulmonary vein in lung cancer: Significance in assessing local extent with CT. 22 (4) 587-591
106. Ann Thorac Surg 1998; Weder W, et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. 66: 886-893
107. J Thorac Cardiovasc Surg 1997; Landreneau RJ, et al. Wedge resection versus lobectomy for stage I (T1N0M0) non-small cell lung cancer. 113: 691-700
108. J Thorac Imaging 1998; Storto ML, et al. Neoplastic extension across pulmonary fissures: Value of spiral computed tomography and multiplanar reformations. 13: 204-210
109. Radiology 1998; Macari M, et al. Non-small cell lung carcinoma: Usefullness of unenhanced helical CT of the adrenal glands in an unmonitored environment. 209: 807-812.
110: Chest 1999; Yokoi K, et al. Detection of brain metastasis in potentially operable non-small cell lung cancer. A comparison of CT and MRI. 115: 714-719
111. Radiology 1999; Earnest F, et al. Suspected non-small cell lung cancer: Incidence of occult brain and skeletal metastases and effectiveness of imaging for detection- pilot study. 211: 137-145
112. Ann Thorac Surg 1999; Klepetko W, et al. T4 lung tumors with infiltration of the thoracic aorta: Is operation reasonable? 67: 340-344
113. Chest 1999; Leong SS, et al. The 1997 international staging system for non-small cell lung cancer. Have all the issues been addressed? 15: 242-248
114. Radiology 1999; Patz EF, et al. Lung cancer staging and management: Comparison of contrast-enhance and nonenhanced helical CT of the thorax. 212: 56-60
115. Radiology 1999; Cox JE, et al. Transthoracic needle aspiration biopsy: Variables that affect risk of pneumothorax. 212: 165-168
116. Ann Thorac Surg 1999; Downey RJ, et al. Extent of chest wall invasion and survivial in patients with lung cancer. 68: 188-193
117. Ann Thorac Surg 1999; Demmy TL, Curtis JJ. Minimally invasive lobectomy directed toward frail and high-risk patients: A case-control study. 68: 194-200
118. J Thorac Cardiovasc Surg 1998; Inoune, et al. Diagnositc assessment of 1310 patients with non-small cell lung cancer who underwent complete resection from 1980-1993; 116: 407-411
119. Chest 1999; Adebonjo SA, et al. Impact of revised stage classification of lung cancer on survival. A military experience. 115: 1507-1513
120. Radiology 1999; Marom EM, et al. Staging non-small cell lung cancer with whole-body PET. 2121: 80-809
121. J Thorac Imag 1999; Bepler G. Lung cancer epidemiology and genetics. 14: 228-234
122. J Thorac Imag 1999; Quint LE, Francis IR. Radiologic staging of lung cancer. 14: 235-246
123. J Thorac Imag 1999; Kelly K, Mikhaeel-Kamel N. Medical treatment of lung cancer. 14: 257-265
124. Radiology 1999; Dwamena BA, et al. Metastases from non-small cell lung cancer: Mediastinal staging in the 1990s- meta-analytic comparison of PET and CT. 213: 530-536
125. Chest 1999; Strauss GM. Role of chemotherapy in stages I to III non-small cell lung cancer. 116: 509S-516S
126. Chest 1999; Friedberg JS. Clinical presentation of stage IIIA (N2) non-small cell lung cancer. Role of multimodality therapy. 116: 497S-499S
127. Ann Thorac Surg 1999; Rocco G, et al. Prognostic factors after surgical treatment of lung cancer invading the diaphragm. 68: 2065-2068
128. AJR 2000; Patz EF, et al. Prognostic value of thoracic FDG PET imaging after treatment for non-small cell lung cancer. 174: 769-774
129. Chest 2000; Gupta NC, et al. Comparative efficacy of positron emission tomography with fluorodeoxyglucose in evaluation of small (<1cm), intermediate (1 to 3 cm), and large (>3 cm) lymph node lesions. 117: 773-778
130. Radiology 2000; Farrell MA, et al. Non-small cell lung cancer: FDG PET for nodal staging in patients with stage I disease. 215: 886-890
131. AJR 2000; Erasmus JJ, et al. FDG PET of pleural effusions in patients with non-small cell lung cancer. 175: 245-249
132. Radiology 2000; Goo JM, et al. Pulmonary tuberculoma evaluated by means of FDG PET: Findings in 10 cases. 216: 117-121
133. N Engl J Med 2000; Pieterman RM, et al. Preoperative staging of non-small-cell lung cancer with positron-emission tomography. 343: 254-261
134. Chest 2000; van Rens MTM, et al. Survival in synchronous vs single lung cancer. Upstaging better reflects prognosis. 118: 952-958
135: AJR 1997; Erasmus JJ, et al. Evaluation of adrenal masses in patients with bronchogenic carcinoma using 18-F-Fluorodeoxyglucose positron emission tomography. 168: 1357-1360
136. Chest 2000; McCain TW, et al. The usefulness of positron emission tomography in evaluating patients for pulmonary malignancies. 118: 1610-1615
137. Thorax 1998; Lowe VJ, Naunheim KS. Current role of positron emission tomography in thoracic oncology. 53: 703-712
138. Ann Thorac Surg 1998; Lowe VJ, Naunheim KS. Positron emission tomography in lung cancer. 65: 1821-29
139. J Nucl Med 1999; Coleman RE. PET in lung cancer. 40: 814-820
140. J Clin Oncol 2001; Kalff V, et al. Clinical impact of 18F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: A prospective study. 19: 111-118
141. Ann Thorac Surg 1999; Saunders CAB, et al. Evaluation of fluorodeoxyglucose whole body positron emission tomography in the staging of lung cancer. 67: 790-97
142. Chest 2001; Dunagan DP, et al. Staging by positron emission tomography predicts survival in patients with non-small cell lung cancer. 119: 333-339
143. Ann Thorac Surg 1999; Kernstine KH, et al. PET, CT, and MRI with combidex for mediastinal staging in non-small cell lung carcinoma. 68: 1022-28
144. J Nucl Med 2001; Hicks RJ, et al. 18F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer. 42: 1596-1604
145. J Nucl Med 2001; Hicks RJ, et al. The utility of 18F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact in management and prognostic stratification. 42: 1605-1613
146. Radiol Clin N Am 2001; Hagge RJ, et al. Positron emission tomography. Brain tumors and lung cancer. 39: 871-881
147. J Nucl Med 2001; Yun M, et al. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. 42: 1795-1799
148. J Clin Oncol 2001; Depierre A, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small cell lung cancer. 20: 247-253
149. AJR 2002; Aquino SL, et al. Improved image interpretation with registered thoracic CT and positron emission tomography data sets. 178: 939-944
150. J Nucl Med 2002; Seltzer MA, et al. The impact of PET on the management of lung cancer: the referring physicians perspective. 43: 752-756
151. Lancet 2002; van Tinteren H, et al. Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicenter randomised trial. 359: 1388-92
152. Radiology 2003; Antoch G, et al. Non-small cell lung cancer: dual-modality PET/CT in preoperative staging. 229: 526-533
153. Radiology 2004; Rohren EM, et al. Clinical applications of PET in oncology. 231: 305-332
154. Radiology 2004; Schaffler GJ, et al. Non-small cell lung cancer: evaluation of pleural abnormalities on CT scans with 18F FDG PET. 231: 858-865
155. Radiology 2004; van Overhagen H, et al. Metastases in supraclavicular lymph nodes in lung cancer: assessment with palpation, US, and CT. 232: 75-80
156. AJR 2004; Gadaleta C, et al. Radiofrequency ablation of 40 lung neoplasms: preliminary results. 183: 361-368
157. Radiographics 2004; Lee KS, et al. T1 non-small cell lung cancer: imaging and histopathologic findings and their prognostic implications. 24: 1617-1636
158. J Nucl Med 2004; Kumar R, et al. 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. 45: 2058-2062
159. Radiol Clin N Am 2005; Mavi A, et al. Fluorodeoxyglucose-PET in characterizing solitary pulmonary nodules, assessing pleural diseases, and the initial staging, restaging, therapy planning, and monitoring response of lung cancer. 43: 1-21
160. Radiol Clin N Am 2005; Munden RF, Bruzzi J. Imaging non-small cell lung cancer. 43: 467-480
161. J Nucl Med 2005; Even-Sapir E. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities. 46: 1356-1367
162. Radiology 2005; Shim SS, et al. Non-small cell lung cancer: prospective comparison of integrated FDG PET/C and CT alone for preoperative staging. 236: 1011-1019
163. Radiology 2005; Onn A, et al. Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor clinical outcome. 237: 342-347
164. Radiology 2005; Munden RF, et al. Imaging of the patient with non-small cell lung cancer. 237: 803-818
165. J Nucl Med 2006; Metser U, et al. 18F-FDG PET/CT in the evaluation of adrenal masses. 47: 32-37
166. Radiology 2006; Blake MA, et al. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy- initial experience. 238: 970-977
167. J Nucl Med 2006; Bunyaviroch T, Coleman RE. PET evaluation of lung cancer. 47: 451-469
168. AJR 2006; Shim SS, et al. Do hemodynamic studies of stage T1 lung cancer enable the prediction of hilar or mediastinal nodal metastases? 186: 981-988
169. AJR 2006; Bruzzi JF, et al. Incidental findings on integrated PET/CT that do not accumulate 18F-FDG. 187: 1116-1123
170. J Nucl Med 2006; Posther KE, et al. Yield of brain 18F-FDG PET in evaluating patients with potentially operable non-small cell lung cancer. 47: 1607-1611
171. J Thorac Cardiovasc Surg 2003; Reed CE, et al. Results of the American college of surgeons oncology group Z0050 trial: utility of positron emission tomography in staging potentially operable non-small cell lung cancer. 126: 1943-1951
172. Radiology 2006; Kim BT, et al. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT- a prospective study. 241: 501-509
173. Ann Thorac Surg; Bryant AS, et al. Satellite pulmonary nodule in the same lobe (T4N0) should not be staged as IIIB non-small cell lung cancer. 82: 1808-14
174. Ann Thorac Surg 2006; Nwogu C, et al. Radioguided detection of lymph node metastasis in non-small cell lung cancer. 82: 1815-1820
175. AJR 2007; Yi CA, et al. Efficacy of helical dynamic CT versus integrated PET/CT for detection of mediastinal nodal metastasis in non-small cell lung cancer. 188: 318-325
176. Chest 2007; Kraev A, et al. Wedge resection vs lobectomy. 10-year survival in stage I primary lung cancer. 131: 136-140
177. Br J Cancer 2005; Nakamura H, et al. Survival following lobectomy vs limited resection for stage I lung cancer: a meta-analysis. 92: 1033-1037
178. J Nucl Med 2007; Kuehl H, et al. Can PET/CT replace separate diagnostic CT for cancer imaging? Optimizing CT protocols for imaging cancers of the chest and abdomen. 48: 45S-57S
179. J Thorac Cardiovasc Surg 2007; Lee BE, et al. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer. 133: 746-752
180. Radiology 2007; Mujoomdar A, et al. Clinical predictors of metastatic disease to the brain from non-small cell lung carcinoma: primary tumor size, cell type, and lymph node metastases. 242: 882-888
181. J Nucl Med 2007; Hellwig D, et al. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense? 48: 1761-1766
182. JAMA 2008; Wallace MB, et al. Minimally invasive endoscopic staging of suspected lung cancer. 299: 540-546
183. Radiographics 2008; Bruzzi JF, et al. Imaging of non-small cell lung cancer of the superior sulcus. Part 1: anatomy, clinical manifestations, and management. 28: 551-560
184. Radiology 2008; Yi CA, et al. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. 248: 632-642
185. Radiology 2008; Ohno Y, et al. Non-small cell lung cancer: whole-body MR examination for M-stage assessment - utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. 248: 643-654
186. Ann Thorac Surg 2008; Misthos P, et al. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer. 86: 1626-1631
187. J Nucl Med 2009; Morikawa M, et al. The effectiveness of 18F-FDG PET/CT comboned with STIR MRI for diagnosing nodal involvement in the thorax. 50: 81-87
188. Radiology 2009; Brady MJ, et al. Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm. 250:523-530
(189) Ann Thorac Surg 2009; Pennathur A, et al. Surgical resection is jsutified in non-small cell lung cancer patients with node negative T4 satellite lesions. 87: 893-899
(190) AJR 2009; Yeh DW, et al. Mediastinal nodes in patients with non-small cell lung cancer: MRI findings with PET/CT and pathologic correlation. 193: 813-821
(191) N Engl J Med 2009; Fischer B, et al. Preoperative staging of lung cancer with combined PET-CT. 361: 32-39
(192) Ann Thorac Cardiovasc Surg 2009; Rami-Porta R, et al. The revised TNM staging system for lung cancer. 15: 4-9
(193) Radiology 2009; Godoy MCB, Naidich DP. Subsolid pulmonary nodules and the spectrum of peripheral adenocarcinomas of the lung: recommended interim guidelines for assessment and management. 253: 606-622
(194) Radiology 2010; Beland MD, et al. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation. 254: 301-307
(195) AJR 2010; Kligerman S, Abbott G. A radiologic review of the new TNM classification for lung cancer. 194: 562-573
(196) AJR 2010; Jeon TY, et al. Incremental value of PET/CT over CT for mediastinal nodal staging of non-small cell lung cancer: comparison between patients with and without idiopathic pulmonary fibrosis. 195: 370-376
(197) Radiographics 2010; UyBico SJ, et al. Lung cancer staging essentials: the new TNM staging system and potential imaging pitfalls. 30: 1163-1181
(198) J Nucl Med 2010; Schreyogg J, et al. Cost-effectiveness of hybrid PET/CT for staging of non-small cell lung cancer. 51: 1668-1675
(199) JAMA 2010; Annema JT, et al. Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer. A randomized trial. 304: 2245-2252
(200) Radiographics 2011; Nair A, et al. Revisions to the TNM
staging of non-small cell lung cancer: rationale,
clinicoradiologic implications, and persistent limitations. 31:
215-238
(201) Radiology 2011; Dupuy DE. Image-guided thermal ablation of
lung malignancies. 260: 633-655
(202) Radiology 2011; Xie L, et al. Non-small cell lung cancer: prognostic importance of positive FDG PET findings in the mediastinum for patients with N0-N1 disease at pathologic analysis. 261: 226-234
(203) Radiology 2011; Ohno Y, et al. N stage disease in patients
with non-small cell lung caner: efficacy of quantitative and
qualitative assessment with STIR turbo spin-echo imaging,
diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT. 261:
605-615
(204) J Nucl Med 2012; Gregory DL, et al.
Effect of PET/CT on management of patients with non-small cell
lung cancer: results of a prospective study with 5-year survival
data. 53: 1007-1015
(205) Radiology 2013; Imai K, et al. Use of
CT to evaluate pleural invasion in non-small cell lung cancer:
measurement of the ratio of the interface between tumor and
neighboring structures to maximum tumor diameter. 267: 619-626
(206) J Nucl Med 2014; Zeliadt SB, et al
Preoperative PET and the reduction of unneccesary surgery among
newly diagnosed lung cancer patients in a community setting. 55:
379-385
(207) AJR 2016; Shen G, et al. Performance of
DWI in nodal characterization and assessment of lung cancer: a
meta-analysis. 206: 283-290
(208) Radiology 2016; Peerlings J, et al. The
diagnostic value of MR imaging in determining the lymph node
status of patients with non-small cell lung cancer: a
meta-analysis. 281: 86-98
(209) Radiology 2013; Imai K, et al. Use of
CT to evaluate pleural invasion in non-small cell lung cancer:
measurement of the ratio of the interface between tumor and
neighboring structures to maximum tumor diameter. 267: 619-626
(210) Radiology 2016; Hsu JS, et al Pleural
tags on CT scans to predict visceral pleural invasion of
non-small cell lung cancer that does not abut the pleura. 279:
590-596
(211) J Thorac
Oncol 2008; Travis D, et al. Visceral pleural invasion:
pathologic criteria and use of elastic stains. 3: 1384-1390
(212) AJR 2017; Ahn SY, et al. Predictive CT
features of visceral pleural invasion by T1-sized peripheral
pulmonary adenocarcinomas manifesting as subsolid nodules. 209:
561-566
(213) J Nucl Med 2017; Steiger S, et al.
Analysis of prognostic values of various PET metrics in
preoperative 18F-FDG PET for early-stage
bronchial carcinoma for progression-free and overall survival:
significantly increased glycolysis is a predictive factor. 58:
1925-1930
(214) Radiographics 2018; Carter BW, et al. Revisions to the TNM
staging of lung cancer: rationale, significance, and clinical
application. 38: 374-391
(215) Radiographics 2018; Kandathil A, et al. Role of FDG PET/CT
in the eight edition of TNM staging of non-small cell lung cancer.
38: 2134-2149
(216) Radiology 2019; Kim H, et al. CT-defnied visceral pleural
invasion in T1 lung adenocarcinoma: lack of relationship to
disease-free survival. 292: 741-749
(217) AJR 2019; Chen L, et al. A radiologists guide to the
changing treatment paradigm of advanced non-small cell lung
cancer: the ASCO 2018 molecular testing guidelines and target therapies.
213: 1047-1058
